Description
Professor, Clinician/Scholar or Physician/Scientist, Leukemia Program Head
The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) invite nominations and applications to lead the Leukemia Program. The Program Head will oversee the research and clinical programs in acute myeloid leukemia (AML) and other myeloid malignancies. The full-time position will be dual appointed with a primary faculty appointment in either the Translational Science and Therapeutics Division (Physician/Scientist) or the Clinical Research Division (Clinician/Scholar) at Fred Hutch and a secondary appointment in the UW Department of Medicine, Division of Hematology and Oncology. The position will report to the Senior Vice President (SVP) of their Division at Fred Hutch and the Division Head of Hematology and Oncology at the UW. We anticipate that this individual will actively contribute to our core values of diversity, openness, innovation, and scientific excellence.
We seek a highly motivated, visionary and accomplished scientific and clinical program head to lead our Program. This role offers an exceptional opportunity to drive cutting-edge research, enhance clinical outcomes, help eradicate disparities, and lead a multidisciplinary team in a dynamic and supportive environment.
The Program Head will oversee and strategically guide the Program, ensuring alignment with the institution's mission and goals. They will develop and implement a comprehensive vision and strategy for AML and myeloid malignancies throughout the entire disease spectrum, integrating basic, translational and clinical research with clinical care. The Program Head will lead and/or support groundbreaking research initiatives, including preclinical studies, clinical trials, and translational research and will foster collaborations with bench researchers, translational researchers and clinical investigators at UW and Fred Hutch. The Program Head will serve as an academic, clinical and educational leader charged with organizing, directing and expanding the research efforts for an established team of clinical researchers involved in conducting trials. Fred Hutch and UW faculty engage in teaching, research, and service. Teaching responsibilities may include attending on clinical service, classroom instruction, mentoring, supervising and or lab instruction. Responsibilities include assisting with faculty recruitment as well as oversight and mentorship of faculty, promotion of professional development for team members and representation of the Program at national and international conferences, workshops, and symposia. The incumbent will build and maintain strong relationships with external stakeholders, including industry partners, regulatory agencies, and funding organizations.
Appointment at Fred Hutch would be at the rank of full professor in the Translational Science and Therapeutics Division or Clinical Research Division. Appointment to the full-time faculty at the UW would be at the rank of full professor, without tenure due to funding (WOT). Full professors hold indefinite appointments that align with a 12-month service period (July 1-June 30). Faculty with 12-month service periods are paid for 11 months of service over a 12-month period (July-June), meaning the equivalent of one month is available for paid time off.
Opportunities exist for joint and/or affiliate appointment in the Fred Hutch Divisions of Public Health Sciences, Translational Science and Therapeutics, Clinical Research Division, Human Biology, Basic Sciences, or Vaccine and Infectious Disease, depending on mutual interests. Fred Hutch and University of Washington faculty engage in teaching, research, and service.
The successful candidate will be appointed in the Clinician Scholar or Physician Scientist track and will spend at least 20% of time on clinical care depending on whether the candidate is laboratory-based or a clinical investigator, and taking into account the amount of research funding. The remainder of the incumbent's time will be protected for research, administrative oversight of the Fred Hutch/UW AML and myeloid malignancies efforts, teaching and mentorship.
This position is paid directly by Fred Hutchinson Cancer Center (Fred Hutch) and receives no UW compensation. Please refer to Fred Hutch for information about compensation and benefits for this position.
Anticipated Start Date: July 1, 2025
Qualifications
Applicants must have:
• MD/DO degree (or foreign equivalent)
• Board certification in hematology and/or medical oncology (or foreign equivalent)
• Eligibility for medical licensure in the state of Washington.
In order to be eligible for University sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE) or equivalent as determined by the Secretary of Health and Human Services.
Competitive candidates will have an international reputation of leadership in AML and/or myeloid malignancies research and clinical excellence. They will have a long-standing track record of substantial basic, translational and/or clinical research with a strong publishing record and NIH grant funding.
Application Instructions
Interested candidates should submit the following:
1) Letter of interest addressed to the Co-Chairs of the Leukemia Program Head Search Advisory Committee, Drs. Jan Abkowitz and Jerry Radich
2) Curriculum vitae
3) Personal statement discussing research accomplishments, leadership experience, and outlining a vision for the growth and development of the program (one page)
4) Diversity, equity, and inclusion statement describing past contributions to diversity, equity, and inclusion and future plans for continuing these efforts (two pages or less)
5) List of five (5) references (References will not be contacted without first discussing this with the applicant).
